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Fatigue is a frequent symptom reported by persons living with HIV disease and one that affects all
aspects of quality of life. To improve quality of care of
persons with HIV disease, it is important to address all
factors that contribute to fatigue. The purpose of this
study was to determine the associations of physiological, psychological, and sociological factors with
fatigue in an HIV-infected population. With Piper’s
integrated fatigue model guiding selection, factors
examined in this study were hemoglobin, hematocrit,
CD4+ cell count, HIV-RNA viral load, total sleep
time, sleep quality, daytime sleepiness, HIV-related
symptoms, anxiety, depression, and perceived stress.
The sample (N = 79) for this descriptive correlational
study was recruited from a primary health care association in South Carolina and consisted of 42 (53.2%)
HIV-infected women and 37 (46.8%) HIV-infected
men between the ages of 24 and 63 years (x = 39.9, s =
7.9). Of the participants, 70 (90%) were African
American, 5 (6%) were Caucasian, and 3 (4%) were
Hispanic. Using Pearson’s r, significant relationships
were observed between fatigue and sleep quality, daytime sleepiness, HIV-related symptoms, state anxiety,
trait anxiety, depression, and perceived stress. Sleep
quality (F5,65 = 12.02, P = 0.0009), state anxiety
(F5,65 = 8.28, P = 0.0054), HIV-related symptoms
(F5,65 = 4.87, P = 0.0308), and depression (F5,65 =
7.31, P = 0.0087) retained significance in a 3-step,
backward stepwise elimination model and accounted
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for 67% of the variance in fatigue. These findings
underscore the need for addressing psychosocial
stressors and sleep quality in developing effective care
for HIV-infected individuals who experience fatigue.
Key words: sleep, anxiety, perceived stress,
depression, HIV, fatigue
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atigue, one of the most prevalent and distressful
symptoms of HIV infection (Barroso and Lynn 2002),
affects all aspects of an individual’s life. A multitude
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Figure 1. Piper’s integrated fatigue model.

of factors may contribute to the fatigue experienced by
an HIV-infected individual. Understanding correlates
of fatigue allows nurses to plan and provide the holistic care that is most appropriate for an HIV-infected
individual who is experiencing fatigue. The purpose of
this study was to determine the physiological, psychological, and sociological correlates of HIV-related
fatigue.

Theoretical Framework
Piper’s integrated fatigue model guided the selection of variables that were examined in this study
(Piper and others 1987; Piper 1989; see Fig. 1). Piper
has proposed that fatigue has temporal, sensory,
cognitive/mental, affective/emotional, behavioral,
and physiological dimensions and that it may arise
from physiological, psychological, or sociological etiologies. Physiological, psychological, and sociological factors theoretically linked with HIV-related fatigue were examined in the present study.

Background
Fatigue has been defined as “a feeling of tiredness
that is influenced by circadian rhythm and occurs on a

continuum that has self-perceived energy or vigor at
its other end” (Grady and others 1998, p 227). Attributes of fatigue that are often identified include tiredness, lack of energy, exhaustion, lethargy, depression,
inability to concentrate, malaise, asthenia, boredom,
sleepiness, lack of motivation, and decreased mental
status (Winningham and others 1994; Rose and others
1998).
Fatigue is a debilitating symptom that almost always accompanies HIV/AIDS (Darko and others
1992; Hoover and others 1993; O’Dell and others
1996; Rondanelli and others 1997; Breitbart and others 1998; Barroso 1999; Barroso and Lynn 2002;
Wollmann and others 2002; Barroso and others 2003)
and is sometimes experienced by otherwise asymptomatic HIV-infected individuals (Hoover and others
1993; Enwonwu and others 1996; Grady and others
1998; Newshan and others 2002; Sullivan and others
2003). HIV-infected individuals have identified fatigue as the most distressful symptom they must endure (O’Brien and Pheifer 1993; Nokes and others
1994).
The prevalence of fatigue in HIV disease ranges
from 20% to 60% (Longo and others 1990; Darko and
others 1992; Hoover and others 1993; Vlahov and others 1994; Breitbart and others 1998; Barroso 1999;
Sullivan and others 2003). During the acute phase of
the primary infection with HIV, fatigue occurs in most
persons. During the asymptomatic phase of the illness,
little or no fatigue is experienced. As HIV infection
progresses to AIDS, fatigue becomes a persistent, severe symptom (Kaslow and others 1987; Lang and
others 1987; Groopman 1998). In a recent study, the
most frequently experienced symptoms reported by
HIV-infected individuals in an urban outpatient clinic
were fatigue, trouble sleeping, anxiety, and pain
(Newshan and others 2002).
Although research has focused on the etiology of
fatigue associated with HIV infection, the mechanisms have remained elusive. A major obstacle is the
inclusion of various populations in the fatigue research. Some researchers have demonstrated a gender
difference in fatigue. Women (67%) with AIDS have
been found to be more likely to report fatigue than men
(49%) with AIDS (Breitbart and others 1998; Sullivan
and others 2003). Intravenous drug users (IVDUs) reported more fatigue than homosexual men who were
not IVDUs. Female IVDUs reported more fatigue than
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male IVDUs (Breitbart and others 1998).
Unsurprisingly, patients older than 35 years reported
more fatigue than did younger patients (Singh and
others 1997).
Fatigue has been reported in association with opportunistic infections (Cohen and others 1999), the
wasting syndrome (Macallan and others 1995), adrenal insufficiency (Piedrola and others 1996), thyroid
deficiency (Barroso 1999; Adinolfi 2001b), and
hypogonadism (Rabkin and others 2000). HIV-related
fatigue is often idiopathic (Carr and others 2000).
Fatigue and Medical Therapy
Fatigue is one of the most commonly reported adverse reactions to antiretroviral medications (Duran
and others 2001; McMahon and others 2001; Kessler
and others 2002). Fatigue has been identified as a major reason for nonadherence to highly active
antiretroviral therapy (HAART; Hagberg and Janson
2001; Molassiotis and others 2002; Monreal and others 2002; Ostrow and others 2002). Reverse transcriptase inhibitors and protease inhibitors are thought to
produce fatigue through their toxic effects on skeletal
muscle (Molassiotis and others 2002). Fatigue may
signal lactic acidosis, a serious and often fatal reaction
to nucleoside reverse transcriptase inhibitors (Carr and
others 2000; Delgado and others 2001; Anonymous
2002). A number of other approved and investigational drugs, such as interleukin-2, are known to lead
to increased fatigue in HIV-infected patients (Grady
and others 1998).

common type of anemia (Phillips and Groër 2002).
Anemia adversely affects a range of the dimensions of
quality of life, most commonly mediated through
fatigue (Moyle 2002).
Clinically, the relationship between anemia and fatigue is well accepted. However, some researchers
have been unable to show a clear association. For example, a poor association was found between anemia
and fatigue in patients with different types of cancer
(Morant 1996), and no correlation was found between
anemia and fatigue in patients with advanced breast
cancer (Bruera and others 1989). O’Dell and colleagues (1996) found no significant relationships
between hemoglobin, hematocrit, albumin, or total
protein and fatigue in 20 HIV-positive men and concluded that fatigue is more related to psychosocial factors than to anemia.
Fatigue and Insomnia
Darko and colleagues (1992) found that HIVinfected subjects were more likely to report fatigue
than were noninfected subjects, and the HIV-infected
subjects were more likely to sleep longer and take
more naps. Lee and others (1999) examined the relationship of fatigue to sleep and activity patterns in HIV
disease. When compared to women with low fatigue
levels, women with high fatigue levels reported more
difficulty falling asleep, more awakening from nighttime sleep, poorer daytime functioning, and a higher
frequency of depressive symptoms.
Fatigue and CD4+ Cell Count

Fatigue and Anemia
Anemia is a common complication in persons with
HIV disease. Anemia affects approximately 3.4 million Americans and is more common in women and
persons living in the South (National Center for Health
Statistics 1996). Fatigue is commonly reported by anemic individuals (Moyle 2002) and is a cardinal symptom in the diagnostic criteria for anemia. Profound
anemia has serious consequences for HIV-infected individuals in that it has been identified as a prognostic
indicator of HIV disease progression and death
(Moyle 2002). Although all classifications of anemia
are possible in HIV disease and must be differentiated
for treatment, the anemia of chronic illness is the most

Contradictory findings have been reported regarding the relationship between CD4+ cell count and fatigue. Some researchers have reported a significant inverse relationship between CD4+ cell count and
fatigue (Darko and others 1992; O’Dell and others
1996; Walker and others 1997; Justice and others
1999); however, other researchers have found no relationship between CD4+ cell count and fatigue (de
Boer and others 1993; Perkins and others 1995;
Breitbart and others 1998; Barroso and others 2003;
Sullivan and others 2003). Lee and colleagues (1999)
reported significant inverse relationships between
CD4+ cell count and evening and morning fatigue in a
sample of HIV-infected women.
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Fatigue and HIV-RNA Viral Load
The relationship between HIV-RNA viral load and
fatigue remains uncertain. Lavreys and colleagues
(2002) examined the relationship between viral load
and the constitutional symptoms of primary HIV infection prior to seroconversion and reported a significant relationship between HIV-RNA viral load and fatigue in that population. Other researchers have found
no relationship between fatigue and HIV-RNA viral
load (Ferrando and others 1998; Barroso and others
2003; Sullivan and others 2003).
Fatigue and Anxiety
Anxiety is a recognized correlate of fatigue in HIV/
AIDS (Groopman 1998). In a study of anxiety syndromes and symptoms in 173 homosexual men with
AIDS, Sewell and colleagues (2000) found a positive
relationship between anxiety and fatigue. Other researchers have reported similar relationships between
anxiety and fatigue in HIV disease (Barroso and others
2003).
Fatigue and Depression
Fatigue, depression, and weight loss are commonly
reported by HIV-infected individuals (Perkins and
others 1995). Health care providers may incorrectly
attribute these symptoms to disease progression and
fail to recognize their patients’ underlying depression.
Unfortunately, it is difficult to sort out the relationship
between fatigue and depression (Walker and others
1997). Instruments used to measure depression commonly include somatic complaints/symptoms that are
similar to symptoms of fatigue. In addition, it is recognized that fatigue is a major symptom of depression.
Significant relationships between depression and
fatigue have been reported in samples of HIV-positive
individuals (Perkins and others 1995; Walker and others 1997; Breitbart and others 1998; Barroso and others 2003). However, some researchers suggest that fatigue in HIV-positive individuals may be a symptom of
underlying depression, whereas others suggest that it
is a physical symptom independent of mood. Ferrando
and colleagues (1998) investigated the prevalence of
fatigue in HIV illness and whether fatigue, being associated with depression, independently affects physical

functioning and disability. These authors concluded
that although fatigue is associated with depression, it
does not seem to be merely a symptom of depression.
They also concluded that fatigue independently contributes to physical limitations and disability and
should therefore be independently assessed and
treated. On the other hand, other studies have suggested that fatigue is a manifestation of depression in
HIV illness (Perkins and others 1995; Lyketsos and
others 1996). Perkins and colleagues (1995) found
that depressive symptoms and major depression were
predictors of fatigue severity. In addition, Lyketsos
and colleagues (1996) found that fatigue and depressive symptoms were closely associated across stages
of HIV illness and concluded that fatigue is most likely
a symptom of depression. Other researchers found a
close association between somatic symptoms of depression and the number of AIDS-related diagnoses.
Almost 50% of their sample reported depressive
symptoms, and more than two-thirds of the subjects
reported fatigue (Kalichman and others 1995).
Therefore, the authors concluded that the assessment
of depression in individuals with HIV-related
symptoms should include only instruments without
somatic symptoms.
Fatigue and Perceived Stress
Using the Global Fatigue Index as a measure of fatigue, Bormann and others (2001) reported a significant direct correlation between perceived stress and
fatigue in a sample of HIV-infected individuals.
Breitbart and others (1998) found that HIV-infected
patients with fatigue report a greater degree of overall
psychological distress.
Fatigue and Quality of Life
Fatigue is strongly related to quality of life (Darko
and o thers 1992; Cleary and others 1993;
Winningham and others 1994; Darko, Mitler, and others 1995; Yellen and others 1997; Breitbart and others
1998; Cunningham and others 1998; Groopman 1998;
Eller 2001). Fatigue can disrupt normal activities of
daily living (Winningham and others 1994), reduce
physical functioning (Winningham and others 1994;
Wilson and Cleary 1996; Fleishman and Crystal
1998), and reduce self-care activities (Hart and others
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1990; Rhodes and others 1988). Fatigue affects HIVinfected individuals’ability to work and to take care of
themselves and their families, their physical and emotional well-being, their enjoyment of life, and their
ability to be intimate with their partners (Groopman
1998). Fatigue may be the most important symptom in
an HIV-infected individual’s decision to discontinue
employment, and with that decision comes loss of
income and loss of health insurance (Darko and others
1992).
Summary
Although other researchers have demonstrated significant relationships between these physiological and
psychological factors and fatigue, no report was found
in which all these variables were tested in a single
model. Understanding the variables that best predict
fatigue in HIV-infected individuals will allow health
care practitioners to develop plans of care that focus on
factors related to fatigue in HIV disease.

Method
Design
The data reported in this article were collected as
part of a study designed to examine physiological and
psychological correlates of fatigue in HIV disease. A
descriptive correlational design was used.
Sample
The sample for this report was recruited from a primary health care association in Columbia, South
Carolina. The sample consisted of 79 women and men
documented to be HIV infected. Individuals who were
18 years of age or older, able to read and understand
English at a 6th-grade level, and receiving health care
services at the primary health care association were included in the study. No one was excluded on the basis
of gender or ethnicity.

community health center referred potential participants to the study. Female research assistants who
were specially trained to provide full information regarding the research study and who signed a confidentiality statement collected all data. Participants were
accessed at the time of their medical appointments for
periodic physical examinations and laboratory studies. A nurse directed individuals who were interested
in the study to a large, comfortable conference room in
the same building. The conference room provided
comfort, privacy, and easy access to the participants.
After receiving an informed consent statement and being fully informed of the nature and duration of the
study by the research assistant, individuals who agreed
to participate were asked to read and sign the informed
consent statement. In addition, they were asked to sign
a consent form that gave the primary health care practice permission to release the results of their laboratory
studies (complete blood count, HIV-RNA viral load,
and T helper cell [CD4+]) count to the researchers.
Data were collected using a structured questionnaire, which was completed on the same day the blood
for laboratory tests was drawn. The research assistant
was available to answer any questions the participants
might have about the study. After the participants completed the questionnaire, the research assistant placed
a wrist actigraph on their nondominant arms and instructed them in the care of the wrist actigraph. Participants were asked to wear the wrist actigraph continually for 3 days and nights. Participants and the research
assistants arranged an appointment to return the wrist
actigraphs. When they returned the wrist actigraphs,
the participants were paid $20 for taking part in the
study.
Instruments
Demographic data form. Participants were asked to
report standard demographic variables such as age and
race and HIV-related variables such as route of infection, stage of illness, symptoms, antiretroviral medications, and hematinic medications (particularly erythropoietin and iron).

Procedure
The Office for Research Protection at the University of South Carolina approved the study and its procedures prior to any data collection. Physicians at the

Revised Piper Fatigue Scale (RPFS). The RPFS
was used to measure subjective fatigue. The RPFS
consists of 22 items that are numerically scaled from 0
(no fatigue) to 10 (high fatigue), and there are 5 items
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that give additional clinical information but are not
used in the scoring of fatigue. The RPFS yields a total
fatigue score and 4 subscale scores that reflect the
behavior/severity, affective meaning, sensory, and
cognitive/mood dimensions of fatigue (Piper 1989).
The 22 numerically scaled items are summed to give
the total fatigue score that was used in this study to
measure subjective fatigue. The total fatigue score is
divided by 22 to give a fatigue score that ranges from 0
to 10 (0 = no fatigue, 1 to 3 = mild fatigue, 4 to 6 = moderate fatigue, and 7 to 10 = severe fatigue). The RPFS
demonstrates internal consistency with a Cronbach’s
α of 0.97. A higher score indicates greater subjective
fatigue (Piper and others 1998).
Hemoglobin, hematocrit, HIV-RNA viral load, and
CD4+ cell count. The results of the physiological variables were recorded directly from each individual’s
medical record. Hemoglobin and hematocrit were
used to measure the degree of anemia. HIV-RNA viral
load was measured using reverse transcriptase polymerase chain reaction.
Wrist actigraph. A MiniMotionLogger wrist actigraph (ambulatory monitoring) was used to measure
total sleep time. The wrist actigraph is a small device
about the size of a quarter that was attached to each
participant’s nondominant arm. The wrist actigraph
detects motion, which is converted to an electric signal
by a piezoelectric crystal. Data from the wrist actigraph are downloaded into a microcomputer for analysis. An algorithm converts the signal into periods of
sleep and activity. The wrist actigraph allows the estimation of the following parameters: (1) sleep-onset
latency, (2) wakening after sleep onset, (3) sleep duration, (4) percentage sleep, and (f) total sleep time. Significant correlations have been reported between
polysomnography and the measurements of the wrist
actigraph on sleep-onset latency (r = 0.70, P <
0.0001), wake after sleep onset, (r = 0.25, P < 0.0001),
sleep duration, (r = 0.89, P < 0.0001), and total sleep
period (r = 0.90, P < 0.0001; Cole and others 1992).
These significant correlations support the validity of
this instrument to measure total sleep time. Total sleep
time was used as the measure of sleep activity.
Pittsburgh Sleep Quality Index (PSQI). The PSQI is
a self-report instrument that measures subjective sleep

quality. This instrument contains 19 self-report items.
The instrument yields a total sleep quality score and 7
component scores (sleep quality, sleep latency, sleep
duration, habitual sleep efficiency, sleep disturbances,
use of sleeping medication, and daytime dysfunction).
The total sleep quality score was used to measure sleep
quality. The total sleep quality score has a reported
internal consistency of 0.83 and a test-retest reliability
of 0.85. Validity of the PSQI is supported by its ability
to discriminate controls from depressives and individuals with diagnosed sleep disorders. The findings of
the PSQI are supported by concurrent polysomnography. Possible scores for the total sleep quality scale
range from 0 to 21. “A PSQI global score greater than 5
indicates severe difficulties in at least 3 areas, or moderate difficulties in more than 3 areas” (Buysse and
others 1989). A higher score indicates poorer sleep
quality (Buysse and others 1991).
Epworth Daytime Sleepiness Scale (ESS). The total
score for the ESS was used to measure daytime sleepiness. This scale asks individuals to rate on a scale of 0
to 3 how likely they are to doze off or fall asleep in 8
specific situations. The total score for the ESS has a
reported reliability of 0.83 and a test-retest reliability
of 0.88 for patients. Possible scores can range from 0
to 24. A higher score indicates greater daytime sleepiness (Johns 1991).
HIV-Related Symptom Scale (HSS). The HSS was
used to measure the frequency of HIV-related symptoms. This instrument is composed of 19 symptoms
(e.g., diarrhea, fever, weight loss, white patches in the
mouth) that are commonly experienced by HIVinfected individuals. The HSS asked participants to
rate on a scale of 1 (no problem) to 4 (very much of a
problem) how much of a problem each of the symptoms had been for them during the past month. Two
of the symptoms on the HSS were fatigue and
weakness. These symptoms were not included in
the total score for these analyses because the outcome measure was fatigue. The responses for each
of the remaining 17 items were summed to give a
total HIV-related symptom score. A higher score
indicated that an individual was experiencing
greater frequency of HIV-related symptoms. Reliability was supported in this sample with a
Cronbach’s α of 0.87.
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Table 1.

Description of the Instruments Used

Instrument
Piper Fatigue Scale
Hemoglobin (mg/dL)
Hematocrit (%)
CD4+ cell count (cells/mm3)
HIV-RNA viral load
Total sleep time (min)b
Pittsburgh Sleep Quality Index
Epworth Daytime Sleepiness Scale
HIV Symptom Distress Scale
Spielberger’s State Anxiety Inventory
Spielberger’s Trait Anxiety Inventory
Center for Epidemiological Studies–
Depression
Perceived Stress Scale

xa

s

Potential Range

Actual Range

␣

3.9
12.9
38.3
412
38,577
399.3
12.3
8.4
26.2
40.9
45.2

2.8
1.7
4.9
268
83,621
168.3
3.9
5.9
8.6
13.6
11.4

0–10
.NA
.NA
.NA
.NA
.NA
0–21
0–24
17–68
20–80
20–80

0–9.9
7.8–16.0
24.0–47.7
8–1140
0–516,000
119.7–966.7
5–21
0–22
17–50
20–78
20–74

0.98
.NA
.NA
.NA
.NA
.NA
0.77
0.84
0.87
0.92
0.91

22.3
68.0

11.3
19.2

0–60
0–120

1–47
2–114

0.87
0.95

a. The mean, standard deviation, actual range, and α reported are from the present study.
b. Total sleep time obtained via wrist actigraph.

Spielberger’s State-Trait Anxiety Inventory (STAI).
The STAI is a 40-item Likert-type instrument used to
measure state anxiety (transitory) and trait anxiety
(relatively stable anxiety proneness). There are 20
items for the state anxiety scale and 20 items for the
trait anxiety scale. The participants were asked to
respond to each of the items on a 4-point scale ranging
from 1 (not at all) to 4 (very much so). The state anxiety scale has reported test-retest reliabilities ranging
from 0.16 to 0.92 and internal consistencies ranging
from 0.83 to 0.92. The trait anxiety scale has reported
test-retest reliabilities ranging from 0.73 to 0.92 and
internal consistencies ranging from 0.86 to 0.92. Construct and concurrent validity of the STAI have been
supported in numerous studies. A higher score indicates greater anxiety (Spielberger and others 1971).
Center for Epidemiological Studies Depression
Scale (CES-D). The CES-D is a 4-point, 20-item scale
that measures depressive symptoms. The participants
were asked to rate how often they had experienced the
depressive symptom represented by each of the 20
items in the past week. Responses range from 0 (not at
all to 1 day per week), 1 (1 to 2 days per week), 2 (3 to 4
days per week), to 3 (5 to 7 days per week). Possible
scores for the total scale range from 0 to 60. Reported
internal consistencies for the instrument have ranged
from 0.83 to 0.90. Concurrent and construct validity
have been supported in a number of studies. A higher
score indicates greater depressive symptoms (Radloff

1977). A cutoff point of greater than 16 is widely
accepted as diagnostic of clinical depression (Radloff
1977; Parikh and others 1988; Beekman and others
1997; Houston and others 2001, 2002).
Perceived Stress Scale (PSS). The PSS is a 30-item
instrument that measures perceived stress (Levenstein
and others 1993). The instrument yields a total score
for perceived stress and 7 subscale scores. The instrument can be administered to collect data about general
perceived stress (in the past year or two) or recent perceived stress (in the past month). In this study, the participants were asked to consider the past month and to
rate each of the items on a scale of 1 (almost never) to 4
(usually). The instrument has a reported test-retest
reliability of 0.82 for the General Form, but the Recent
Form varied by a mean factor of 1.9 over 6 months.
Reported internal consistencies were greater than 0.90
for both forms of the PSS. The developers of the PSS
have reported concurrent and construct validity. The
total score was used to measure perceived stress in this
study. A higher score indicates greater perceived stress
(Levenstein and others 1993). The psychometric properties of the instruments used in this study are summarized in Table 1.
Data Analysis
The data were entered by a research assistant and
verified by an independent observer. Frequencies and
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Table 2.

Description of Fatigue Based on the Demographic Characteristics of the Sample

Characteristic

Frequency

Gender
Female
Male
Race
African American
Caucasian
Hispanic
Missing
Partnership status
Single
Partnered or married
Missing
Stage of illness
Asymptomatic
Symptomatic
AIDS
Missing
Antiretroviral therapy
Yes
No
Missing
Fatigue
None (0)
Mild (1–3)
Moderate (4–6)
Severe (7–10)
Missing

%

x Fatigue

s

42
37

46.8
53.2

3.8
4.1

2.8
2.8

70
5
3
1

89.8
6.4
3.8

3.8
4.5
4.6

2.8
3.0
0.9

64
14
1

82.1
17.9

3.8
4.7

2.9
2.1

13
25
18
23

23.2
44.6
32.2

3.0
3.6
3.7

3.0
2.6
2.7

52
24
3

68.4
31.6

3.8
4.2

2.6
3.3

17
22
27
11
2

22.1
28.6
35.1
14.3

0.2
2.7
5.4
8.4

0.3
0.9
0.9
0.9

NOTE: The revised Piper Fatigue Scale was used to obtain measures of subjective fatigue.

percentages were calculated for each of the
sociodemographic variables. Reliabilities for each of
the research instruments were estimated using
Cronbach’s α reliability coefficient. Bivariate correlations were calculated between fatigue and the theoretically selected variables. A P value < 0.05 was established as the level of statistical significance for the
backward stepwise elimination model. Variables that
were significantly related to fatigue in the bivariate
correlations were entered into a backward stepwise
elimination model. Collinearity diagnostics were performed for the variables in the full model. Statistical
power for the backward stepwise regression was
calculated to be 0.80 with a medium effect size in this
sample.

Results
All participants in this study were infected with
HIV. They were predominately African Americans

(n = 70), and 5 were Caucasian and 3 Hispanic. Fortytwo participants were women, and 37 were men. The
majority of the participants were single (n = 64). The
remaining 14 participants reported that they were partnered. The participants ranged in age from 24 to 63
years (x = 39.9, s = 7.8). Thirteen participants were
asymptomatic, 25 were symptomatic, and 18 had developed AIDS. The frequencies do not add to 79 in all
cases due to missing data points. Means, standard deviations, and missing data points are reported in Table 2.
Fifty-two participants were receiving combination
antiretroviral therapy, and 24 (31.6%) were not receiving any antiretroviral therapy. An independent t test
was performed to test whether there was a difference in
the total fatigue scale between participants who were
receiving combination antiretroviral therapy and those
participants who were not taking any antiretroviral
medications. No significant difference was detected
(t = 0.50, P = 0.62).
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Comorbidity was examined in this sample. Ten subjects reported being treated for hypertension; 9 were
treated for depression; 8 were treated for gastroesophageal reflux disease; 5 participants were treated
for diabetes mellitus, all of whom received oral
hypoglycemics and 2 of whom received insulin; 2
were being treated for dyslipidemia; 3 were receiving
appetite stimulants; 25% of the sample was anemic,
with 8 men (21.6%) having a hemoglobin count less
than 14 g/dL and 12 women (28.6%) having a hemoglobin count less than 12 g/dL, thus meeting the criteria for anemia. Two participants reported taking erythropoietin, 5 participants took iron supplements, and 15
participants reported taking multiple vitamins.
Depression scores for this sample ranged from 1 to
47, with a mean of 22.3 ± 11.3. In this sample, 54 participants (68.4%) scored greater than 16 on the CESD, which is consistent with clinical depression. There
was no gender difference in depression scores (independent t test; t = 1.54, P = 0.13).
Description of Fatigue
In our sample of 79 HIV-infected men and women,
we found that 60 participants (77.9%) reported some
degree of fatigue, with 22 (28.6%) reporting mild fatigue, 27 reporting moderate fatigue (35.1%), and 11
(14.3%) reporting severe fatigue (see Table 2).
No differences in total fatigue were observed between men and women (independent t test; t = 0.50, P
= 0.62). Likewise, no significant differences were observed in the total fatigue score between participants
who were asymptomatic, symptomatic, or who had
progressed to AIDS (ANOVA; F2,52 = 0.28, P = 0.75).
Finally, no significant differences in fatigue were observed between those who were taking protease inhibitors and those who were not taking protease inhibitors
(independent t test, t = 0.78, P = 0.45). (Refer to Table
2 for means and standard deviations.)
Bivariate Correlations
Relationships of the demographic variables with total fatigue were tested using Pearson’s coefficient of
correlation (Pearson’s r). No significant relationship
was found between age and total fatigue (Pearson’s
correlation coefficient; r = –0.19, P = 0.17). Significant relationships were observed between fatigue and

sleep quality (r = 0.53, P < 0.0001), daytime sleepiness (r = 0.33, P = 0.0039), HIV-related symptoms (r =
0.61, P < 0.0001), state anxiety (r = 0.71, P < 0.0001),
trait anxiety (r = 0.57, P <. 0.0001), depression (r =
0.65, P < 0.0001), and perceived stress (r = 0.71, P <
0.0001), as shown in Table 3.
Tests for Multiple Collinearity
Because multicollinearity issues are of concern
when multiple psychometric measurements are used
in regression analyses, collinearity diagnostics were
performed for each of the variables in the full model.
All variance inflation factors were <10, and the condition inflation factors were <30, indicating that
multicollinearity was not a problem for this model.
Backward Stepwise Elimination
Subsequently, independent variables (sleep quality,
daytime sleepiness, HIV-related symptoms, state anxiety, trait anxiety, depression, and perceived stress)
that demonstrated a significant association with the
dependent variable (fatigue) were entered into a backward stepwise elimination equation. In a 3-step solution, trait anxiety and perceived stress fell out of the
model. Sleep quality, state anxiety, HIV-related symptoms, and depression retained statistical significance
and explained 67% of the variance in fatigue, as shown
in Table 4.

Discussion
The results from the present study indicate a high
prevalence of fatigue in a predominantly African
American population of HIV-infected individuals.
Our findings regarding the high prevalence of fatigue
in this sample of HIV-infected men and women are
consistent with those of previous researchers (Darko
and others 1992; Hoover and others 1993; O’Dell and
others 1996; Rondanelli and others 1997; Breitbart
and others 1998; Barroso 1999; Barroso and Lynn
2002; Wollmann and others 2002; Barroso and others
2003).
We found no significant relationships between fatigue and gender, race, partnership status, or
antiretroviral therapy. The failure to find a gender difference in fatigue in HIV-infected individuals is incon-
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Table 3.
Variable

1

2

3

4

5

6

7

8

9

10

11

12

a

1. Fatigue
2. Hemoglobin
0.030
3. Hematocrit
0.001
4. CD4+ cells
0.057
5. Viral load
0.249
6. Total sleep
b
–0.084
time
c
7. Sleep quality 0.526****
8. Daytime
d
0.333**
sleepiness
9. Symptomse
0.551****
10. State anxietyf 0.706****
11. Trait anxietyg 0.568****
12. Depressionh
0.645****
13. Perceived
stressi
0.712****

0.977****
0.414** 0.450***
–0.178
–0.166
–0.259
–0.232
–0.041

0.243
0.053

–0.175
0.051

0.335*
–0.028 –0.182

0.149
–0.258*
0.004
0.076
0.188

0.093
–0.320*
0.013
0.043
0.152

–0.269
–0.194
–0.056
0.005
–0.062

–0.023
0.133
0.209
0.107
0.208

–0.072
0.030
–0.097
–0.133
–0.110

0.186
0.287*
0.423****
0.251*
0.297**

0.335**
0.175
0.515****
0.221
0.475**** 0.744****
0.366** 0.492**** 0.678**** 0.780****

0.077

0.056

–0.068

0.163

–0.028

0.411***

0.343** 0.543**** 0.772**** 0.801**** 0.803****

a. Revised Piper Fatigue Scale (total score).
b. Wrist actigraph.
c. Pittsburgh Sleep Quality Index (total score).
d. Epworth Daytime Sleepiness Scale.
e. HIV Symptom Distress Scale.
f. Spielberger’s State Anxiety Inventory.
g. Spielberger’s Trait Anxiety Inventory.
h. Center for Epidemiological Studies–Depression Scale.
i. Perceived Stress Scale.
*P < 0.05. **P < 0.01. ***P < 0.001. ****P < 0.0001.

sistent with the findings of Breitbart and colleagues
(1998) and Sullivan and colleagues (2003). This may
be explained in part by the different methods that were
used in data collection. Sullivan and colleagues collected data via retrospective chart reviews and included only individuals who reported fatigue as the
primary reason for a health care visit, fatigue on more
than one health care visit, or fatigue that limited the patient in his or her employment or sport. Likewise, the
researchers acknowledged use of an instrument that
has a less sensitive case definition for fatigue than the
one we used. Breitbart and colleagues (1998) collected their data to the advent of HAART, more of the
participants had progressed to AIDS, and they used a
dichotomous item to measure the presence of fatigue.
It is likely that the total score for the Piper Fatigue
Scale is a more sensitive measure of fatigue.
There were a number of physiological and psychological characteristics associated with self-reported
fatigue in the subject group. However, the highest

Table 4.

Backward Stepwise Regression Analysis Summary
for Variables Predicting Fatigue

Variable
Intercept
Sleep quality
State anxiety
HIV-related symptoms
Depression

␤
–4.23
0.20
0.06
0.06
0.07

Standard
Error ␤
0.84
0.06
0.03
0.02
0.03

F

P

25.2 < 0.0001
12.0
0.0016
8.3
0.0054
4.9
0.0308
7.3
0.0087

NOTE: R2 = 0.67; Model F5,65 = 31.66, P < 0.0001; N = 71.

correlations with fatigue were found among psychological variables. A backward stepwise regression
emphasized the impact of both psychological and
physiological characteristics, as both types of variables were included in the model that was predictive of
fatigue in the subjects.
Fatigue is the most common clinical complaint of
HIV-infected individuals, with a prevalence range of
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10% to 30% among asymptomatic patients and 40% to
50% among AIDS patients (Adinolfi 2001a, 2001b;
Sullivan and others 2003). Although fatigue is associated with deteriorating physical health, mental wellbeing, and quality of life, it is also predictive of diminishing physical function (Ferrando and others 1998).
Fatigue affects the HIV-infected individual financially, as it generally leads to decreased vigor, lower
quality of work, and increased absenteeism (Darko
and others 1992; Darko, Mitler, and others 1998).
Although fatigue has a clear impact on the overall
quality of life of a large number of HIV-infected individuals, it is difficult to define and measure. Therefore,
the physiological and psychological characteristics responsible for feelings of fatigue have been elusive.
Finding the causes of fatigue is difficult because of the
likelihood that fatigue associated with HIV infection
is the result of a number of pathological conditions
that are constantly in flux. Not surprisingly, there is a
significant amount of conflicting data concerning the
relationships between fatigue and physiological and
psychological characteristics. For example, there are
conflicting reports of the association between fatigue
and CD4+ cell count. One study found an inverse relationship between level of fatigue and CD4+ count in
HIV-infected gay men (Walker and others 1997).
These authors suggest that this relationship may be
caused by exhaustion of the body from fighting infection during advanced stages of HIV. On the other hand,
3 other studies found no relationship between the 2
variables (Ferrando and others 1998; Barroso and
Lynn 2002; Sullivan and others 2003). Our findings
are in support of studies showing no correlations between measures of immune function and reported
symptoms of HIV illness (Rabkin and others 1991;
Perry and others 1992; de Boer and others 1993; Perkins and others 1995; Breitbart and others 1998;
Ferrando and others 1998; Barroso and others 2002;
Sullivan and others 2003).
One interesting outcome of the present study is the
very low prevalence of anemia in the subject group.
Anemia is a common physiological disturbance in
HIV infection, with up to 80% of the population experiencing anemia at some point (Doweiko and
Groopman 1998). Fatigue is arguably the most common presenting symptom associated with anemia. The
anemic condition results from a number of mechanisms including disrupted hematopoiesis, bone mar-

row infection, hemolysis, and antiviral therapy
(Groopman 1998). Unfortunately, although significant technological discoveries have advanced HIV
treatment, there has been little change in the prevalence of anemia in the HIV-infected population
(Mocroft and others 1999). In the present study, only a
relatively small portion of the subjects, about 25%,
presented with anemia. This disproportionately low
number could be due to a number of factors. First, the
incidence of anemia rises along with the number of
symptoms and as the individual reaches AIDS status.
Our participant group consisted of primarily asymptomatic ambulatory individuals. Second, the anemia
associated with HIV infection may be due to nutritional deficiencies (Doweiko and Groopman 1998).
Since our subjects were recruited at a highly recognized primary care facility with a specialization in
HIV infection, it is likely that the individuals’ conditions, including nutritional status, were well managed.
With a range of 5 to 21 on the PSQI, all subjects in
our study reported pathological sleep disturbances.
Our data indicate that the subjects averaged approximately 6.7 ± 2.8 h of sleep per night. Although there
was a wide range of total sleep time and the average
appears to be in the low range, there was no correlation
between total sleep time and fatigue. However, both
sleep quality and daytime sleepiness were correlates
of fatigue. Furthermore, backward stepwise regression analysis indicates that sleep quality is 1 of the 4
determinants of fatigue in our subject population.
These findings would suggest that the feelings of fatigue associated with HIV infection in our group are
likely due to altered sleep patterns rather than hours of
sleep. This possibility is supported by research from
Darko and associates (Darko, Miller, and others 1995;
Darko, Mitler, and others 1995; Darko and others
1998) indicating HIV-dependent changes in nocturnal
secretion of specific hormones that might contribute to
sleep pathologies other than insomnia. These hormonal changes included plasma levels of tumor necrosis factor–α and growth hormone, both of which have
been linked to sleep patterns and resulting sleep quality. A relationship has further been shown between
morning fatigue and measures related to sleep quality,
including duration of wake episodes during the night,
napping, and perception of sleep disturbance during
the past week. In addition, the number of awakenings
throughout the night predicted the severity of fatigue,

Downloaded from http://brn.sagepub.com at UNIV OF TENNESSEE on July 13, 2010

70 BIOLOGICAL RESEARCH FOR NURSING Vol. 6, No. 1, July 2004

and lower CD4+ cell counts were related to greater
daytime sleep and higher morning and evening fatigue
(Lee and others 1999). Thus, it appears that certain
physiological alterations observed in HIV illness
contribute to altered sleep patterns that could result in
feelings of fatigue during the day.
Physical symptoms of HIV infection also affect
sleep variables and showed a relatively high correlation with fatigue in our study. Our subjects reported an
average score of 30.8 ± 10.2 (range = 17–58) out of a
possible 68 on the HSS. Many of these physical symptoms, such as pain, have been shown to contribute to
fatigue in the HIV-infected individual (Breitbart and
others 1998). Symptoms of HIV were included in the
regression model for determinants of fatigue in this
population of infected subjects. Very few studies have
been done using the HSS since it was recently developed. However, the items on the scale are valid; the
Cronbach’s α for the entire tool was 0.94.
Psychological factors have been proposed as the
primary mechanism for fatigue in HIV-positive individuals. In a study examining the relationship between
fatigue and physiological parameters, no significant
associations were found between hematocrit, hemoglobin, total protein, and albumin. The authors concluded that there is a stronger association between
fatigue and psychological parameters than between
fatigue and physiological parameters (O’Dell and others 1996).
We found that a majority of the participants in our
study scored greater than 16 on the CES-D, which indicates a high prevalence of clinical depression in this
sample. Some studies examining the prevalence of depression in HIV patients reporting fatigue have not
supported the hypothesis that HIV-related fatigue is
associated with depression (Walker and others 1997;
Breitbart and others 1998). In our study, depression
and fatigue showed a relatively high correlation. Depression retained significance in the final backward
stepwise elimination model. We support the notion
that the level of depression is associated with the number of symptoms resulting from HIV infection. The
correlation between depression and fatigue may therefore be dependent on the HIV-related symptoms that
partially determine fatigue.
In the present study, both state and trait anxiety correlated with fatigue. Furthermore, state anxiety survived the backward stepwise regression analysis and

was included in the model of determinants of fatigue.
The significant relationships found between state anxiety, trait anxiety, and fatigue are consistent with findings of prior research (Sewell and others 2000;
Barroso and others 2003). Interestingly, both state and
trait anxiety correlated with sleep quality and HIVrelated symptoms. Further investigation will be required to determine the relationship between anxiety,
sleep, and symptoms. However, since sleep quality is
partially dependent on the degree of physical limitation (Gielen and others 2001) and on the individual’s
level of psychological distress (Breitbart and others
1998), to suggest a cyclical interaction of those 3 characteristics that results in fatigue would not be too
speculative. This suggestion is supported by a study
of anxiety syndromes and symptoms in 173 homosexual men with AIDS demonstrating a positive relationship between anxiety and fatigue (Sewell and
others 2000).
In the present study, perceived stress was highly
correlated with fatigue; however, perceived stress did
not hold up in the final regression model when the
other variables were taken into account. Further research is needed to determine whether the relationship
between perceived stress and fatigue may be mediated
by other factors. Perceived stress is not typically examined in fatigue research. Breitbart and others (1998)
found that HIV-infected patients with fatigue report a
greater degree of overall psychological distress, and a
number of studies have shown a higher level of the
stress hormone cortisol in the plasma of HIV-infected
individuals as compared to HIV-negative subjects
(Clerici and others 1997). It is well established that increased unpredictability in a situation will increase
perceived stress and cortisol levels (Malarkey and others 1995; Steptoe and others 1998; Atanackovic and
others 2002). It follows that an individual with a diagnosed HIV infection would have enhanced stress reactivity to other stressors; in fact, hypercortisolemia is
characteristic in the asymptomatic stages of HIV infection. The increased levels of cortisol are related to
increased arousal, decreased sleep, and reduced rapid
eye movement sleep (Born and others 1986). Cortisol
enhances HIV replication as well (Markham and others 1986). Therefore, the association of perceived
stress and fatigue may be mediated by stresshormone-related sleep-quality disruption and other
factors related to increased viral load.
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Study Limitations

Implications for the Integrated Fatigue Model

Although this study presents very useful information, some limitations should be noted. First, the participants for this study were recruited from 1 medical
practice in 1 geographic region, the southeastern
United States. The physicians in that medical practice
referred patients who met the study criteria to the research study. Using this convenience sample may have
resulted in bias through self-selection. The
generalizability of the findings of this study is further
limited in that the sample was predominantly composed of 1 racial group, African Americans. And finally, fatigue may be influenced by a number of
sociodemographic factors that were not collected as
part of this study.

Certainly, this study did not address the integrated
fatigue model in its entirety. However, the findings of
this study do support the multidimensional nature of
the fatigue associated with HIV disease and help to establish the need for considering sleep quality, anxiety,
HIV-related symptoms, and depression in the care of
HIV-infected women and men who are experiencing
fatigue.

Clinical Implications
Fatigue is underreported by patients and
undertreated by health care providers (Justice and others 1999; Adinolfi 2001b; Curt and Johnston 2003). A
reason may be that HIV-infected patients and their
health care providers may not be giving adequate attention to the symptom of fatigue (Groopman 1998).
Health care providers should reconsider whether their
communication skills are facilitative and should question HIV-infected patients about all bothersome symptoms, such as fatigue, at each visit (Eller 2001). Health
care providers should also reassess their perception of
fatigue and their approach to treating fatigue
(Groopman 1998).
Thorough assessment of fatigue is the basis for
planning effective interventions for HIV-related fatigue. That assessment should include its onset, duration, severity, factors that increase and decrease the
level of fatigue, self-care interventions tried by the patient, and the resolution of fatigue. Based on the findings of our study, a thorough psychosocial assessment
is beneficial in helping the fatigued patient. A plan of
care that considers the whole patient (physiologic factors, roles and responsibilities of the patient, support
systems, and factors such as depression and anxiety) is
necessary to help the patient achieve an optimum level
of health. Fatigue level must be reevaluated at each
contact with the patient.

Implications for Future Research
Although this study provides important information about this sample, the descriptive, correlational
design does not allow for causal inference. An important follow-up to this study would be to develop and
test an intervention targeting these factors to see if
such an intervention would decrease fatigue and improve quality of life for HIV-infected individuals. In a
future intervention study, the sample should include a
greater percentage of individuals who are anemic and
who report significant levels of fatigue. The sample
was not adequate to detect fatigue due to anemia. Objective measures of fatigue would provide valuable
insight into metabolic causes.

Conclusion
In summary, the present study examined selected
physiological and psychological correlates of fatigue.
The results indicated that the physiological characteristics of sleep quality, daytime sleepiness, and HIVrelated symptoms correlated with fatigue. The psychological characteristics that correlated with fatigue
were state and trait anxiety, depression, and perceived
stress. A backward stepwise regression model indicated that almost 70% of the variability in fatigue
could be explained in a model containing sleep quality,
state anxiety, HIV-related symptoms, and depression.
These data indicate that the high prevalence of fatigue
in the HIV-infected population is a multifactorial syndrome that includes both physiological and psychological correlates. The results also suggest that stressrelated factors probably contribute significantly to the
fatigue syndrome.
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